Arca
Skip to content
Tools
Tools

von Hippel-Lindau disease

Drug research and approvals for von Hippel-Lindau disease: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 22, 2026, 17 studies of von Hippel-Lindau disease are recruiting on ClinicalTrials.gov, Health Canada has authorized 0 drug trials for it since 2013, and FDA has 1 approved and 1 open orphan designations naming it.

  • Recruiting worldwide: 17
  • Trials authorized in Canada: 0
  • FDA orphan approvals: 1
  • EU medicines: 0

Recruiting now

Newest posted first, of 17 recruiting on ClinicalTrials.gov ↗

Drug pipeline

Each drug at the furthest stage it has reached for this condition, from ChEMBL's drug indications

Approved 1

  • BelzutifanEndothelial PAS domain-containing protein 1 inhibitor

Phase 2 6

Phase 1 or earlier 5

How its trials ended

49 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 10 whose ending is known, 20% met their primary endpoint, 10% missed it and 70% stopped early.

  • Ongoing2347%
  • Completed, result not reported1429%
  • Stopped: enrollment or feasibility36%
  • Stopped: other or unclear36%
  • Met its primary endpoint24%
  • Status unknown24%
  • Missed its primary endpoint12%
  • Stopped: safety12%

FDA orphan designations

Approved first, then open designations, newest first
Aug 13, 2021WeliregTreatment of adult patients with von Hippel-Lindau (VHL) disease who require therapy for associated renal cell carcinoma (RCC), central…Merck Sharp & Dohme, LLCApproved
Mar 23, 20003-(3,5-Dimethyl-1H-2ylmethylene)-1,3-dihydro-indol-2-oneTreatment of von Hippel-Lindau disease.Sugen, Inc.Designated

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.